0000874716-24-000039.txt : 20240216 0000874716-24-000039.hdr.sgml : 20240216 20240216175644 ACCESSION NUMBER: 0000874716-24-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240214 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAZELSKY JONATHAN JAY CENTRAL INDEX KEY: 0001556270 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 24649859 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 FORMER NAME: FORMER CONFORMED NAME: MAZELSKY JAY DATE OF NAME CHANGE: 20120815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 wk-form4_1708124192.xml FORM 4 X0508 4 2024-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001556270 MAZELSKY JONATHAN JAY ONE IDEXX DRIVE WESTBROOK ME 04092 1 1 0 0 President and CEO 0 Common Stock 2024-02-14 4 M 0 435 0 A 79681.5926 D Common Stock 2024-02-14 4 M 0 974 0 A 80655.5926 D Common Stock 2024-02-14 4 M 0 689 0 A 81344.5926 D Common Stock 2024-02-14 4 M 0 958 0 A 82302.5926 D Common Stock 2024-02-14 4 M 0 1100 0 A 83402.5926 D Common Stock 2024-02-14 4 F 0 1839 560.56 D 81563.5926 D Non-Qualified Stock Option (right-to-buy) 560.56 2024-02-14 4 A 0 21335 0 A 2034-02-13 Common Stock 21335 21335 D Incentive Stock Option (right-to-buy) 560.56 2024-02-14 4 A 0 178 0 A 2034-02-13 Common Stock 178 178 D Restricted Stock Unit 2024-02-14 4 M 0 435 0 D Common Stock 435 0 D Restricted Stock Unit 2024-02-14 4 M 0 974 0 D Common Stock 974 0 D Restricted Stock Unit 2024-02-14 4 M 0 689 0 D Common Stock 689 689 D Restricted Stock Unit 2024-02-14 4 M 0 958 0 D Common Stock 958 1916 D Restricted Stock Unit 2024-02-14 4 M 0 1100 0 D Common Stock 1100 3298 D Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028. Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. /s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky 2024-02-16